Lilly’s pancreatic cancer treatment fails late-stage study
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg,…
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co’s lung cancer drug Alimta. Shares of…
Eli Lilly’s hypoglycemia treatment wins FDA approval
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg,…
FDA approves Lilly’s migraine drug as first ever cluster headache treatment
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks,…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in…
Lilly’s diabetes drug data impresses, hurts rival Novo’s shares
(Reuters) – Eli Lilly and Co (LLY.N) said on Thursday its new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending its shares to a record…
U.S. District Court rules in favor of Lilly’s Alimta patent
(Reuters) – Eli Lilly and Co said on Friday a U.S. District Court ruled in favor of its patent on Alimta vitamin regimen and prevented Hospira Inc and India’s Dr.…
VISUAL SIGNATURES: featuring Charles Lilly
VISUAL SIGNATURES is a Public Service Announcement (PSA) that highlights a vast cultural array of visual artists who share with viewers their visions of creating art and the rewards of…
Lilly’s Cyramza succeeds in late-stage liver cancer trial
(Reuters) – Eli Lilly and Co on Wednesday said its drug Cyramza met the main goal of helping patients live longer in a late-stage trial, which tested it as a…